Clinical Trial Update: Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial investigating Nipocalimab for adults with chronic inflammatory demyelinating polyneuropathy (CIDP) is currently recruiting to assess …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Demyelinating Polyneuropathy

Drugs mentioned

• Nipocalimab (nipocalimab)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | Phase 2, Phase 3 | Status: RECRUITING